Hokusai Study in Pediatric Patients With Confirmed Venous Thromboembolism (VTE)

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 290 participants.

Also called NCT02798471

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 290 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT02798471
  • EudraCT 2016-000991-49
  • CTRI CTRI/2018/01/011249
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States, Argentina, Brazil, Bulgaria, Canada, Chile, Croatia, Czechia, Denmark, El Salvador, France, Germany, Guatemala, Hungary, India, Israel, Kenya, Lebanon, Malaysia, Netherlands, Norway, Panama, Portugal, Romania, Russia, Serbia, Singapore, Slovenia, South Korea, Spain, Taiwan, Thailand, Türkiye, Ukraine (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02798471. Randomized; single masking; primary purpose treatment. Start 2017-03-27 (actual); primary completion 2022-05-24 (actual). Results posted on 2023-03-06.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Hokusai Study in Pediatric Patients With Confirmed Venous Thromboembolism (VTE)
Condition
Venous Thromboembolism (VTE)
Intervention (Drug)
Edoxaban
Intervention (Drug)
Standard of Care
Lead sponsor
Daiichi Sankyo (class: industry)

Record details

Record id
cardio:ct-nct02798471
Content hash
201789c342ea56c66d370ed58943c9a7e3a49c5cf5e19fa4743cb2c9be0d0b22